OLD Category: pan cancer panels

Defining the microenvironment landscape of bladder cancer using highly multiplexed spatial genomic and proteomic analysis

• Reeves JW et al.,

Circulating tumor cell and cell-free RNA capture and expression analysis identify platelet-associated genes in metastatic lung cancer

• Beck TN et al.,

Rebalancing protein homeostasis enhances tumor antigen presentation

• Jaeger AM et al.,

Transcriptomic profiles conducive to immune-mediated tumor rejection in human breast cancer skin metastases treated with Imiquimod

• Rozenblit M et al.,

Immune signature profiling identified prognostic factors for gastric cancer

• Yang W et al.,

Differential Effects of Depleting versus Programming Tumor-Associated Macrophages on Engineered T Cells in Pancreatic Ductal Adenocarcinoma

• Stromnes IM et al.,

Identification of the optimal combination dosing schedule of neoadjuvant ipilimumab plus nivolumab in macroscopic stage III melanoma (OpACIN-neo): a multicentre, phase 2, randomised, controlled trial

• Rozeman EA et al.,

Characterization of the tumor immune micromilieu and its interference with outcome after concurrent chemoradiation in patients with oropharyngeal carcinomas

• Hess AK, Jöhrens K, Zakarneh A, Keilholz U, Budach V, Tinhofer I

Gene expression and promoter methylation of angiogenic and lymphangiogenic factors as prognostic markers in melanoma

• Monteiro AC et al.,

Analytical Validation of Multiplex Biomarker Assay to Stratify Colorectal Cancer into Molecular Subtypes

• Ragulan C et al.,

Differential genomic and transcriptomic events associated with high-grade transformation of Chronic Lymphocytic Leukemia

• Klintman J et al.,

Combination of 5-fluorouracil and thymoquinone targets stem cell gene signature in colorectal cancer cells

• Ndreshkjana B et al.,